Press Releases

Name: Medicure Inc.
Address: 1250 Waverley Street, Winnipeg, Manitoba, R3T 6C6
Price range: unknown

Medicure Announces Filing of sNDA for AGGRASTAT Label Change January 8, 2013	Medicure Announces Agreement to Promote Aggrastat® in the Commonwealth of Puerto Rico November 5, 2012	Medicure Completes Share Consolidation November 1, 2012
Medicure Reports First Quarter Financial Results for Fiscal 2013 October 30, 2012	Medicure Announces Intention to Seek Expanded Aggrastat Label October 2, 2012	Medicure Announces Development of Novel AGGRASTAT Formulation September 26, 2012
Medicure Announces Proposed Fifteen to One Share Consolidation September 21, 2012	Medicure Reports Financial Results for Fiscal 2012 September 19, 2012	Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT May 10, 2012
Medicure Reports Third Quarter 2012 Financial Results April 20, 2012	Medicure Announces AGGRASTAT Clinical Trial: SAVI-PCI January 30, 2012	Medicure Reports Second Quarter 2012 Financial Results January 25, 2012
Medicure Provides Update on TEND-TD Phase II Clinical Trial January 23, 2012	Medicure Reports First Quarter 2012 Financial Results November 29, 2011	Medicure Announces Graduation to TSX Venture Exchange October 21, 2011
Medicure Reports Financial Results for Fiscal 2011 September 28, 2011	Medicure Announces Appointment of New CFO September 22, 2011	Medicure Announces Appointment of Dawson Reimer as President and Chief Operating Officer July 25, 2011
Medicure Announces Birmingham Debt Settlement July 18, 2011	Medicure Announces Grant of Options July 18, 2011	Medicure Announces Executive Officer Change July 15, 2011
Medicure International and Iroko Cardio Sign an Agreement for the Advancement of AGGRASTAT® Worldwide July 6, 2011

Newer | Older

Press Releases

Medicure Announces Filing of sNDA for AGGRASTAT Label Change

Medicure Announces Agreement to Promote Aggrastat® in the Commonwealth of Puerto Rico

Medicure Completes Share Consolidation

Medicure Reports First Quarter Financial Results for Fiscal 2013

Medicure Announces Intention to Seek Expanded Aggrastat Label

Medicure Announces Development of Novel AGGRASTAT Formulation

Medicure Announces Proposed Fifteen to One Share Consolidation

Medicure Reports Financial Results for Fiscal 2012

Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT

Medicure Reports Third Quarter 2012 Financial Results

Medicure Announces AGGRASTAT Clinical Trial: SAVI-PCI

Medicure Reports Second Quarter 2012 Financial Results

Medicure Provides Update on TEND-TD Phase II Clinical Trial

Medicure Reports First Quarter 2012 Financial Results

Medicure Announces Graduation to TSX Venture Exchange

Medicure Reports Financial Results for Fiscal 2011

Medicure Announces Appointment of New CFO

Medicure Announces Appointment of Dawson Reimer as President and Chief Operating Officer

Medicure Announces Birmingham Debt Settlement

Medicure Announces Grant of Options

Medicure Announces Executive Officer Change

Medicure International and Iroko Cardio Sign an Agreement for the Advancement of AGGRASTAT® Worldwide

Stay Connected

Sign up for our newsletter

About

Products

News and Media

Investors

Online Pharmacy

Contact Us